Related Experiment Videos
Precision of dual X-ray absorptiometry and peripheral computed tomography using mobile densitometry units
M Wapniarz1, R Lehmann, O Randerath
1Medizinische Universitätsklinik Würzburg, FRG.
Calcified Tissue International
|March 1, 1994
Summary
Mobile densitometry units using dual X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) were tested in German epidemiologic studies. These mobile units demonstrated precision and stability comparable to stationary equipment, reducing intercenter variability in bone mass measurements.
Area of Science:
- Medical Imaging
- Bone Densitometry
- Epidemiology
Background:
- Comparing bone mass data across different centers is challenging due to significant interunit variation in noninvasive measurement methods.
- Standardization of bone densitometry is crucial for large-scale epidemiologic studies and clinical trials.
Purpose of the Study:
- To evaluate the effectiveness of mobile densitometry units in reducing interunit variability for bone mass determination.
- To assess the precision and stability of mobile dual X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) scanners.
Main Methods:
- Two mobile densitometry units were deployed across Germany, one equipped with DXA (QDR 1000 Hologic) and the other with pQCT (XCT 900 Stratec).
- In vitro precision was assessed using hydroxyapatite phantoms.
- In vivo reproducibility was evaluated through duplicate measurements on 48 patients at the lumbar spine and hip.
Main Results:
- Long-term in vitro precision for DXA instruments was 0.41% and 0.59% for bone mineral density (BMD), with minimal machine drift.
- Short-term in vivo reproducibility showed coefficients of variation of 1.02% for spinal BMD and 1.72% for femoral neck BMD.
- Long-term in vitro precision for the pQCT scanner was 0.9%.
Conclusions:
- Mobile densitometry units achieve precision and stability comparable to stationary equipment.
- Mobile densitometry is a viable tool for epidemiologic surveys, clinical trials, and routine bone mass evaluation in remote areas.